Charleston, SC -- (SBWIRE) -- 12/19/2013 -- Hot Shot Stock Alerts is a market and commodities news and marketing web service, providing investing news, business news, headline news, news alerts, personal finance, stock market, and press releases. Hot Shot Stock Alerts carries you the most fascinating reviews and research reports regarding following stocks: Celgene Corporation (NASDAQ:CELG), MannKind Corporation (NASDAQ:MNKD), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Geron Corporation (NASDAQ:GERN)
Celgene Corporation (NASDAQ:CELG) finished last trade at $162.48, gaining +1.05%. Trading volume recorded for this company was about 3.52 million shares as compared to its average volume of 2.88 million shares. The share price rushed almost +6.21% in the last one month while its 52 week high is $173.80. The company has the total of 412.07 million outstanding shares while its market capitalization is now about $66.95 billion.
Celgene Corporation discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe. Its commercial stage products include REVLIMID, a drug to treat multiple myeloma and transfusion-dependent anemia.
What was the Moving Force behind CELG On Bullish Run? Read This Research Report
MannKind Corporation (NASDAQ:MNKD) closed at $4.96, up +0.43%, on volume of over 3.49 million shares. The share price fell -3.13% in the last 5 days. The company has an average trading volume of 4.29 million shares. In the time frame of the last one month, shares surged almost +1.64%. Its market capitalization was $1.77 billion.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States.
For How Long MNKD will Fight for Profitability? Read This Trend Analysis report
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) traded with +1.98% gain momentum to $55.18 in the latest trading session It captured $3.35 billion in market value. The total number of shares traded on the latest trading day was about 3.30M shares. The day started out with an opening price of $52.26 and changed hands at price range of $52.08 to $55.20 apiece.
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of multiple sclerosis, nephrotic syndrome, and infantile spasms indications. It primarily offers H.P. Acthar Gel, an injectable drug for the treatment of acute exacerbations of multiple sclerosis in adults.
For How Long QCOR’s Gloss will Attract Investors? Find out via this report
Geron Corporation (NASDAQ:GERN) shares touched a high of $4.76 before closing at $4.69, a plunge of -0.21%. The trading volume was 3.27 million shares. Its shares advanced about +232.62% since the start of year and has a +75.00% gain momentum in last three months. Narrowing down the performance period, the stock fell -7.68% for the month and a +0.64% gain over the week.
Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
Has GERN Found The Bottom and Ready To Move Up? Find Out Here
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list.
Never invest into a stock discussed on this web site or the HotShotStockAlerts.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
HotShotStockAlerts.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.
Read full Disclaimer at: http://hotshotstockalerts.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)